A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer

NCT05509790 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: LY3484356

Sponsor

Eli Lilly and Company